Literature DB >> 11812249

Cognitive and sedative effects of benzodiazepine use.

S E Buffett-Jerrott1, S H Stewart.   

Abstract

This paper reviews the effects of benzodiazepines (BZs) on the performance of tasks measuring human cognitive abilities. The paper reviews the most common cognitive side effects of BZs: increased sedation, decreased attention, and anterograde amnesia. In particular, this paper focuses on recent findings regarding time course-related effects on BZ-induced deficits in explicit and implicit human memory performance. Specifically, we reviewed recent research indicating that both explicit memory and priming are impaired by BZs if the encoding task takes place near the time of the theoretical peak plasma concentrations of the drug. Although BZs also appear to increase objective and subjective sedation, as well as to impair attentional processing, these other cognitive impairments do not appear to fully account for the widespread memory deficits caused by BZ administration. The theoretical and clinical implications of benzodiazepine-induced memory impairments are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812249     DOI: 10.2174/1381612023396654

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  66 in total

1.  Effects of midazolam on explicit vs implicit memory in a pediatric surgery setting.

Authors:  Sherry H Stewart; Susan E Buffett-Jerrott; G Allen Finley; Kristi D Wright; Teresa Valois Gomez
Journal:  Psychopharmacology (Berl)       Date:  2006-04-22       Impact factor: 4.530

2.  Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.

Authors:  L B Krupp; C Christodoulou; P Melville; W F Scherl; L-Y Pai; L R Muenz; D He; R H B Benedict; A Goodman; S Rizvi; S R Schwid; B Weinstock-Guttman; H J Westervelt; H Wishart
Journal:  Neurology       Date:  2011-04-26       Impact factor: 9.910

3.  Administration of the benzodiazepine midazolam increases tau phosphorylation in the mouse brain.

Authors:  Robert A Whittington; László Virág; Maud Gratuze; Hilana Lewkowitz-Shpuntoff; Mehdi Cheheltanan; Franck Petry; Isabelle Poitras; Françoise Morin; Emmanuel Planel
Journal:  Neurobiol Aging       Date:  2018-11-08       Impact factor: 4.673

4.  How do different age groups use benzodiazepines and antidepressants? Analysis of an Australian administrative database, 2003-6.

Authors:  Alesha J Smith; Sue E Tett
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

5.  Investigation of changes in EEG complexity during memory retrieval: the effect of midazolam.

Authors:  Nasibeh Talebi; Ali M Nasrabadi; Tim Curran
Journal:  Cogn Neurodyn       Date:  2012-07-22       Impact factor: 5.082

Review 6.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

7.  Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data.

Authors:  Fabienne A Biétry; Alena M Pfeil; Oliver Reich; Matthias Schwenkglenks; Christoph R Meier
Journal:  CNS Drugs       Date:  2017-03       Impact factor: 5.749

8.  Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study.

Authors:  Angela Federico; Stefano Tamburin; Alice Maier; Marco Faccini; Rebecca Casari; Laura Morbioli; Fabio Lugoboni
Journal:  Neurol Sci       Date:  2016-10-11       Impact factor: 3.307

9.  Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats.

Authors:  M Diez-Ariza; C Redondo; M García-Alloza; B Lasheras; J Del Río; M J Ramírez
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

10.  Effects of benzodiazepines on explicit memory in a paediatric surgery setting.

Authors:  Susan E Buffett-Jerrott; Sherry H Stewart; G Allen Finley; Heather Lee Loughlan
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.